Search

Your search keyword '"Anne Noonan"' showing total 4 results
Start Over Author "Anne Noonan" Topic humans
4 results on '"Anne Noonan"'

1. Altered Plasma Fatty Acid Abundance Is Associated with Cachexia in Treatment-Naïve Pancreatic Cancer

Author

Kristyn Gumpper-Fedus, Phil A. Hart, Martha A. Belury, Olivia Crowe, Rachel M. Cole, Valentina Pita Grisanti, Niharika Badi, Sophia Liva, Alice Hinton, Christopher Coss, Mitchell L. Ramsey, Anne Noonan, Darwin L. Conwell, and Zobeida Cruz-Monserrate

Subjects
Pancreatic Neoplasms, Cachexia, Linoleic Acids, digestive, oral, and skin physiology, Fatty Acids, Humans, General Medicine, Adenocarcinoma, musculoskeletal system, pancreatic cancer, fatty acids, sarcopenia, diabetes, hemoglobin, albumin, oleic acid, linoleic acid, Carcinoma, Pancreatic Ductal, Oleic Acid
Abstract

Cachexia occurs in up to 80% of pancreatic ductal adenocarcinoma (PDAC) patients and is characterized by unintentional weight loss and tissue wasting. To understand the metabolic changes that occur in PDAC-associated cachexia, we compared the abundance of plasma fatty acids (FAs), measured by gas chromatography, of subjects with treatment-naïve metastatic PDAC with or without cachexia, defined as a loss of > 2% weight and evidence of sarcopenia (n = 43). The abundance of saturated, monounsaturated, and polyunsaturated FAs was not different between subjects with cachexia and those without. Oleic acid was significantly higher in subjects with cachexia (p = 0.0007) and diabetes (p = 0.015). Lauric (r = 0.592, p = 0.0096) and eicosapentaenoic (r = 0.564, p = 0.015) acids were positively correlated with age in cachexia patients. Subjects with diabetes (p = 0.021) or both diabetes and cachexia (p = 0.092) had low palmitic:oleic acid ratios. Linoleic acid was lower in subjects with diabetes (p = 0.018) and correlated with hemoglobin (r = 0.519, p = 0.033) and albumin (r = 0.577, p = 0.015) in subjects with cachexia. Oleic or linoleic acid may be useful treatment targets or biomarkers of cachexia in patients with metastatic PDAC, particularly those with diabetes.

Published
2022

2. Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience

Author

Anupama, Suresh, Akannsha, Ganju, Evan, Morgan, Marilly, Palettas, Julie A, Stephens, Joseph, Liu, Michael, Berger, Craig, Vargo, Anne, Noonan, Raquel, Reinbolt, Mathew, Cherian, Jeffrey, VanDeusen, Sagar, Sardesai, Robert, Wesolowski, Daniel G, Stover, Maryam, Lustberg, Bhuvaneswari, Ramaswamy, and Nicole, Williams

Subjects
Adult, Antimetabolites, Antineoplastic, Humans, Breast Neoplasms, Female, Kaplan-Meier Estimate, Treatment Failure, Middle Aged, Capecitabine, Drug Administration Schedule, Aged, Retrospective Studies
Abstract

Purpose Capecitabine is widely used as a single agent on a 21-day cycle in the management of metastatic breast cancer (MBC). Our primary objective was to compare the standard dosing of capecitabine (Arm A: days 1-14 on 21-day cycle) to biweekly dosing (Arm B: days 1-7 and 15-21 on 28-day cycle) using retrospective data analysis. Methods 166 patients with MBC treated with single agent capecitabine at The Ohio State University from 2002 to 2014 were considered eligible. Median time to treatment failure (TTF) and overall survival (OS) were estimated using Kaplan-Meier (KM) methods. KM curves were compared using log-rank tests with Holm's correction for multiplicity. Results Patients were grouped by dose schedule into one of three arms: Arm A (21-day cycle; capecitabine given at 1000 mg/m

Published
2019

3. Databases for Congenital Heart Defect Public Health Studies Across the Lifespan

Author

Tiffany J. Riehle‐Colarusso, Lisa Bergersen, Craig S. Broberg, Cynthia H. Cassell, Darryl T. Gray, Scott D. Grosse, Jeffrey P. Jacobs, Marshall L. Jacobs, Russell S. Kirby, Lazaros Kochilas, Asha Krishnaswamy, Arianne Marelli, Sara K. Pasquali, Thalia Wood, Matthew E. Oster, Ginnie Lee Abarbanell, Faith Adams, Steven W. Allen, Sydney Allen, Anand Ambrose, Carl Lewis Backer, Andrea Baer, Carissa Marie Baker‐Smith, Mona Barmash, Amy Basken, Cassandra Bates, Sarosh Percy Batlivala, Robert H. Beekman, John William Belmont, Joshua Benke, Stuart Berger, JR Bockerstette, Jeffrey R. Boris, Lorenzo Botto, Jackie Boucher, Dana Brock Hageman, Cheryl Brosig Soto, Kristin Marie Burns, Lenore Cameron, Robert M. Campbell, Steven E. Colan, Lynn Colegrove, Christina Coleman, Angie Colson, Adolfo Correa, Pamela Costa, Chris Couser, Melissa Lynnn Crenshaw, Tessa Crume, Rachel Daskalov, Mark D. Del Monte, Lindsay DeSantis, Kaitlin Doherty, Kenneth Dooley, Charles (Wes) Duke, Pirooz Eghtesady, Saiza Elayda, Alison Ellison, Tim Elsner, Cori Erntz, Michelle Z. Esquivel, Bethany Evans, Lloyd Robert Feit, Marcia Feldkamp, William Foley, Elyse Foster, Wayne Franklin, Bridget Freeley, Frank M. Galioto, Mary George, Michael H. Gewitz, Katja Michelle Gist, Thomas Glenn, Melissa (Jill) Glidewell, Lorraine A. Gore, Johanna Gray, Hannah Green, Michelle Z. Gurvitz, Sonia Handa, Melissa Harvey, Emilie Heath, Danielle Hile, John Smith Hokanson, Margaret (Peggy) Honein, Marius M. Hubbell, Jeff Hudson, Kelly Huhn, Dawn Ilardi, Dawn C. Jacobs, Robert Douglas Benjamin Jaquiss, Kathy J. Jenkins, Anitha John, Patrick Johnson, Shakila Johnson, Emily Jones, Antonios P. Jossif, Jonathan Ross Kaltman, David Kasnic, Alex R. Kemper, Natalie Kenny, Paul Khairy, Valerie King, Donna Knapp, Daisuke Kobayashi, Adrienne Kovacs, James Kucik, Karen S. Kuehl, Alexandra Kuznetsov, Scott Leezer, Jodi Lemacks, Patty Libby, Paul H. Lipkin, Michele Ann Lloyd‐Puryear, Keila Natilde Lopez, Nicolas L. Madsen, Cara Mai, Monica Mann, Bradley Marino, Gerard Robert Martin, G. Paul Matherne, Phillip Mauller, Susan May, Edward R. B. McCabe, Nancy McCabe, Michelle McCardle, Ty McCathran, Amy McCathran, Michael E. McConnell, Kristine Brite McCormick, Eric Melsom, William Kelly Milionis, Paula Miller, Erika Miller, Stephanie Mitchell, Cynthia A. Moore, Laura Morris, Angela Murray, Kathleen Mussatto, Steven R. Neish, Sue Nelson, Jane W. Newburger, Jeremy Nicolarsen, Autumn Niggles, Jacqueline Anne Noonan, Gail Ober, Lori O'Keefe, Marc Overcash, Jennifer Page, Matthew Vaughn Park, Mehul D. Patel, Jasmin Patel, Gail Denise Pearson, Cindy Pellegrini, Corrie Pierce, Nelangi M. Pinto, Kara Polen, Jose Alcides Quinones, Carol Raimondi, Pat Richter, Michelle Rintamaki, Elisa Robles, Geoffrey L. Rosenthal, Grahame Rush, Laura Russell, Annamarie Saarinen, Craig Andrew Sable, Joel Saltz, Terri Schaefer, Kathryn Schubert, Vida Schwartz, Stuart K. Shapira, Kathleen Sheehan, Brenda Silverman, Regina Simeone, Juanita Smith, Kimberly E. Smith, Kristina Smith, Marci Sontag, Shubhika Srivastava, Corrie Stassen, Corey Stiver, Kathryn Taubert, Judy Thibadeau, John P. Thomas, Dena Thomas, Vivian Baldassari Thorne, Linda Tiernan, Susan Timmins, Colby Tiner, Natalie Torentinos, Glenn Tringali, James S. Tweddell, Lisa M. Vasquez, Amy Verstappen, Janice Ware, Caron Watkins, Catherine L. Webb, Ellen Weiss, Marina Weiss, Gil Wernovsky, Gretchen Whitehurst, Herbert Whitley, Jennifer Witten, Austin Henry Wong, Matthew Wright, Robert Wynbrant, and Bistra Zheleva

Subjects
Heart Defects, Congenital, Gerontology, medicine.medical_specialty, databases, Databases, Factual, Epidemiology, Heart defect, 030204 cardiovascular system & hematology, Global Health, Pediatrics, 03 medical and health sciences, Health services, 0302 clinical medicine, 030225 pediatrics, Contemporary Review, Global health, Humans, Medicine, Contemporary Reviews, Quality and Outcomes, Life span, business.industry, Public health, Health Services, congenital heart defects, Disease control, Public Health, Mortality/Survival, Morbidity, Cardiology and Cardiovascular Medicine, Mortality survival, business, public health science
Abstract

In a 2012 meeting at the Centers for Disease Control and Prevention (CDC), key experts and stakeholders identified public health knowledge gaps about congenital heart defects (CHDs), namely prevalence of CHDs across the life span, long‐term outcomes of persons with CHDs, and health services

Published
2016
Full Text
View/download PDF

4. Marathon of eponyms: 14 Noonan syndrome

Author

C, Scully, J, Langdon, and Jacqueline Anne, Noonan

Subjects
Eponyms, Noonan Syndrome, Humans, History, 20th Century, United States
Abstract

The use of eponyms has long been contentious, but many remain in common use, as discussed elsewhere (Editorial: Oral Diseases. 2009: 15; 185). The use of eponyms in diseases of the head and neck is found mainly in specialties dealing with medically compromised individuals (paediatric dentistry, special care dentistry, oral and maxillofacial medicine, oral and maxillofacial pathology, oral and maxillofacial radiology and oral and maxillofacial surgery) and particularly by hospital-centred practitioners. This series has selected some of the more recognised relevant eponymous conditions and presents them alphabetically. The information is based largely on data available from MEDLINE and a number of internet websites as noted below: the authors would welcome any corrections. This document summarises data about Noonan syndrome.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results